Trials / Recruiting
RecruitingNCT05289245
A National Registry on Chinese Patients With Cystic Fibrosis
A National Registry on Clinical Manifestations, Genetics, Interventions, and Outcomes in Chinese Patients With Cystic Fibrosis (CF-CHINA)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Cystic fibrosis (CF) is a rare autosomal recessive disease involving multiple organs, especially the lungs and digestive organs. It is most commonly seen in Caucasians. Only a few Chinese CF patients have been described in literature, taking into account the large population of China. The main objectives of this study are to accurately evaluate the prevalence of CF, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.
Conditions
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2032-10-01
- Completion
- 2032-10-01
- First posted
- 2022-03-21
- Last updated
- 2022-03-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05289245. Inclusion in this directory is not an endorsement.